Half-year report · HY
7634.TEDINET S100X1C2
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥7.4bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥15.1bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥864m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥881m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥918m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥925m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥916m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥925m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥622m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥623m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥627m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥634m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥25.4bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥24.6bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥23.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥5.9bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥19.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥18.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥18.1bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.6bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥976m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥5.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥401m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥740m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥412m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥199.22 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥469.18 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥199.7 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 75.5% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.2% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 54
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥511m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥511m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥60m |
| Care Welfare Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥582m |
| Care Welfare Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥582m |
| Care Welfare Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥60,000 |
| Home Medical Treatment Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥3.6bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥431m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥651m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥614m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥92m |
| Medical Gas Relatedreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥283m |
| Nursing Homereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥176m |
| Nursing Homereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥176m |
| Nursing Homereportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥2m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥6.9bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥6.9bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥804m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥7.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥37m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥864m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥490m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥490m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥62m |
| Care Welfare Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥581m |
| Care Welfare Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥581m |
| Care Welfare Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥20m |
| Home Medical Treatment Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Home Medical Treatment Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Home Medical Treatment Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥400m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥850m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥806m |
| Medical Gas Equipment Installation Relatedreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| Medical Gas Equipment Installation Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥107m |
| Medical Gas Relatedreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| Medical Gas Relatedreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥291m |
| Nursing Homereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥174m |
| Nursing Homereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥174m |
| Nursing Homereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥783,000 |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥6.8bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥6.8bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥819m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥7.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥881m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 500
| Item | Context | Value | Unit |
|---|---|---|---|
| Name major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)星 幸 男 | |
| Address major shareholders | InterimInstant_No5MajorShareholdersMember | Original text (Japanese)埼玉県川口市 | |
| Name major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)星 孝 子 | |
| Address major shareholders | InterimInstant_No6MajorShareholdersMember | Original text (Japanese)東京都港区 | |
| Name major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)星 昌 成 | |
| Address major shareholders | InterimInstant_No7MajorShareholdersMember | Original text (Japanese)東京都千代田区 | |
| Name major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)星医療酸器従業員持株会 | |
| Address major shareholders | InterimInstant_No8MajorShareholdersMember | Original text (Japanese)東京都足立区入谷七丁目11番18号 | |
| Name major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)小池酸素工業株式会社 | |
| Address major shareholders | InterimInstant_No9MajorShareholdersMember | Original text (Japanese)東京都墨田区太平三丁目４番８号 | |
| Name major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)星 昌 浩 | |
| Address major shareholders | InterimInstant_No10MajorShareholdersMember | Original text (Japanese)埼玉県川口市 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | Original text (Japanese)株主としての権利内容に制限のない、標準となる株式 | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)同上 | |
| Description issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | Original text (Japanese)同上 | |
| Treasury shares etc (text) | FilingDateInstant | Text · Plus | |
| Name of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)株式会社星医療酸器 | |
| Address of shareholder treasury shares etc | InterimInstant_Row1Member | Original text (Japanese)東京都足立区入谷七丁目11番18号 | |
| Information about officers (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated financial statements financial information | InterimDuration | Text · Plus | |
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes uncertainties of entitys ability to continue as going concern semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes accounting treatments specific to semi annual financial statements type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes additional information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes regarding inventories (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and semi annual financial statements (text) | Prior1InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Description of nature of differences between profit loss of reportable segments total and semi annual financial statements (text) | InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |